Drugs / AMT-562
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06199908 | May 2024 → Dec 2025 | cancer | Multitude Therapeutics | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMT-562 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06199908 ↗ |
| Route | Intravenous | “Administered AMT-562 for injection intravenously” NCT06199908 ↗ |